Attention Deficit Hyperactivity disorder (ADHD)
Join a study exploring potential treatments with a new class of investigational medication.
A clinical trial is enrolling children aged 4-5 with Attention Deificit
Hyperactivity Disorder (ADHD)
To pre-qualify for this study, participants must:
Be between 4 years 0 months and 5 years 9 months of age at the time of screening and considered medically healthy.
Have a primary diagnosis of ADHD according to DSM-IV-TR criteria, confirmed with the Kiddie schedule for affective disorders and schizophrenia.
Be participating in a structured group activity (e.g., preschool, kindergarten, sports, or child care) to assess symptoms and impairment in settings outside the home.